These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 15400236)

  • 1. [Current state of research on PAS [par-amino-salicylate] derivatives].
    CURCI G
    Arch Tisiol Mal Appar Respir; 1949; 4(5):Varia, 169-72. PubMed ID: 15400236
    [No Abstract]   [Full Text] [Related]  

  • 2. Salicylate detection on urine in PAS treatment.
    BARTHOLOMEW AT
    Am J Med Technol; 1962; 28():288-90. PubMed ID: 13969691
    [No Abstract]   [Full Text] [Related]  

  • 3. DISAPPEARANCE OF WAXY EXUDATES IN DIABETIC RETINOPATHY DURING ADMINSTRATION OF P-AMINO-SALICYLATE (PAS).
    ESMANN V; JENSEN HJ; LUNDBAEK K
    Acta Med Scand; 1963 Jul; 174():99-104. PubMed ID: 14042470
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of rheumatic infection with PAS and with PAS associated with sodium salicylate; determination in the blood and therapeutic considerations].
    BULGARELLI R; SARDINI G
    Minerva Pediatr; 1954 Mar; 6(6):198-201. PubMed ID: 13165349
    [No Abstract]   [Full Text] [Related]  

  • 5. Knocking out salicylate biosynthesis genes in Mycobacterium smegmatis induces hypersensitivity to p-aminosalicylate (PAS).
    Nagachar N; Ratledge C
    FEMS Microbiol Lett; 2010 Oct; 311(2):193-9. PubMed ID: 20735479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Limits of the efficacy of PAS in primary pulmonary tuberculosis and indications for associated PAS-streptomycin treatment; research and considerations on 185 cases].
    BULGARELLI R
    Minerva Pediatr; 1950 Jul; 2(7):287-311. PubMed ID: 15438890
    [No Abstract]   [Full Text] [Related]  

  • 7. [Influence of single and repeated doses of salicylic acid, p-aminosalicylic acid, disodium salicylate and sodium salts of p-aminosalicylic acid on prothrombinemia in the rabbit].
    MARRAS G
    Boll Soc Ital Biol Sper; 1951; 27(1-2):44-6. PubMed ID: 14848278
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapeutic effect of para-amino-salicylate on tuberculosis].
    MIZUSAWA M; NAGASAWA K
    Kekkaku; 1952 May; 27(5):238-42. PubMed ID: 12981738
    [No Abstract]   [Full Text] [Related]  

  • 9. [PAS in the treatment of tuberculosis].
    de los RIOS F
    Med Cir Guerra; 1950 May; 12(5):233-43. PubMed ID: 15429665
    [No Abstract]   [Full Text] [Related]  

  • 10. [Streptomycin resistance and PAS resistance].
    VUGA D
    Minerva Pediatr; 1950 Apr; 2(4):170-2. PubMed ID: 15423311
    [No Abstract]   [Full Text] [Related]  

  • 11. [Paraaminosalicylic acid alone and with sodium salicylate in therapy of rheumatic infection].
    BULGARELLI R; SARDINI G
    Minerva Pediatr; 1952 Dec; 4(23):1033-4. PubMed ID: 13046313
    [No Abstract]   [Full Text] [Related]  

  • 12. [Report on a year's experience with PAS in treatment of tuberculosis].
    HAUSS WH; HEUCKEROTH E
    Dtsch Med Wochenschr; 1950 Jun; 75(26):895-8. PubMed ID: 15435194
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hemolytic manifestations and hematomedullary examinations in Sardinian children during PAS therapy].
    DEPPERU E; RICCARDI M
    Pediatria (Napoli); 1950; 58(3-4):184-97. PubMed ID: 15440214
    [No Abstract]   [Full Text] [Related]  

  • 14. Para-aminosalicylsyra (PAS) ett nytt kemoterapeutikum.
    ROSDAHL KG
    Sven Farm Tidskr; 1949 Jul; 53(19):353-66. PubMed ID: 18140127
    [No Abstract]   [Full Text] [Related]  

  • 15. [Derivatives of p-amino-salicylic acid].
    RAFFA L
    Farmaco Sci Tec; 1949; 4(4):444-52. PubMed ID: 18142266
    [No Abstract]   [Full Text] [Related]  

  • 16. [Tuberculostatic effect of several PAS preparations in vitro].
    WALTER AM
    Dtsch Med Wochenschr; 1950 Apr; 75(17):587. PubMed ID: 15421145
    [No Abstract]   [Full Text] [Related]  

  • 17. [Analytic study of PAS and the product of its decarboxylation; use of various methods in analyzing different pharmaceutical preparations].
    THOMAS G; ROLAND P; VANDEN BULCKE A
    J Pharm Belg; 1950; 5(5-6):103-16. PubMed ID: 15428975
    [No Abstract]   [Full Text] [Related]  

  • 18. [Considerations on the behavior of blood and CSF concentrations in children subjected to the introduction of PAS by various routes].
    CARNEVALE A; CUTILLO S
    Pediatria (Rio); 1949; 57(5-6):365-72. PubMed ID: 18137830
    [No Abstract]   [Full Text] [Related]  

  • 19. [Menorrhagia and lengthening of the time of coagulation in patients treated with PAS].
    DUFOURT A; OLLAGNIER R; TOURAINE R; CAJGFINGER H
    Lyon Med; 1950 Apr; 183(18):288-90. PubMed ID: 15416205
    [No Abstract]   [Full Text] [Related]  

  • 20. [A case of osteomalacia induced by oral administration of calcium alumino-p-amino-salicylate (author's transl)].
    Nakashima H; Yoshida H; Kawamura Y; Muto Y; Takahashi Y
    Nihon Naika Gakkai Zasshi; 1980 Apr; 69(4):477-82. PubMed ID: 7391635
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.